Isolation of bioactive neolignans from leaves of Nectandra leucantha, preparation of salt derivatives and evaluation of antitumoral activities

vol. 1, 2019 - 117658
Poster
Favorite this paper
How to cite this paper?
Abstract

Melanoma is a malignant neoplasia of melanocytes, being considered the most aggressive and lethal type of cancer, due to its ability to generate metastases. The main problem associated with treatment is the lack of responses to existing therapies [1]. Due to this, researches highlight a great potential for the discovery of new compounds with antitumor activity in plants of the Brazilian biodiversity. In this context, the Nectandra leucantha species, whose prominent feature is the presence of neolignans, has been showing a promising in vitro pharmacological antimelanoma potential [2]. This study aimed to isolate bioactive compounds 1 and 2 using a LiChroprep® RP-18 column (Merck) and hydroethanol solution, in polarity gradient, as eluent. From 500 mg of N. leucantha leaf extract, 74.3 mg of dehydrodieugenol B (1) and 5 mg of dehydrodieugenol (2) were isolated. Both compounds were characterized by 1H and 13C NMR, as well as by LC/MS, and their structures were confirmed with published data [2,3]. Due to the lipophilic characteristic of 1 and 2, as soon as it crystalize/precipitate at aqueous solutions, and aiming an increasing in hydrophilicity, the semi-synthesis strategy was used to obtain the respective sodium phenolates (Figure 1). Thus, phenolic compounds 1 and 2 were treated with absolute methanol and one equivalent/mol of metallic sodium for each hydroxyl [4]. The structural confirmation of salts was performed by LC/MS, since both, the starting material and the final product (1a and 2a) have the same ions by MS, but with different interactions with the stationary phase, and different Rt (LC). Saline compounds (1a and 2a), as well as, their precursors were evaluated for 1 and 2 displayed IC50 of 110.3 and 57.2 μM against A372 strain, respectively, and only compound 2 demonstrated cytotoxic activity against B16F10 (IC50 50.2 μM). On the other hand, their saline derivatives were inactive at the maximum tested concentrations (IC50> 200 M) compared to all strains tested. In view, we suggest that the -OH in these compounds, are preferable for antitumor activity rather than fundamental, since studies indicate, at least for antiparasitic activity, -OH is not essential for activity [5]. Therefore, we conclude that the salinification strategy was not the most suitable for increasing hidrophilicity, and strategies that do not involve functional group exchange, such as, nanoformulations, are suggested.

References:
[1] FIGUEIREDO C.R. et al. Pharmacognosy Magazine, v. 10, p. 363-76, 2014.
[2] SOUSA, F. S. et al. Phytochemistry v. 140, p. 108-117, 2017.
[3] GRECCO, S. S. et al.. Phytomedicine, Vol. 24, p. 62-67, 2017.
[4] FAIÃO-FLORES, F. et al J. PLoS ONE 10(3): e0118702, 2015.
[5] FERREIRA, D.D. et al European Journal of Medicinal Chemistry, V. 176, p. 162-174, 2019.

Institutions
  • 1 ANHANGUERA EDUCACIONAL
  • 2 Instituto de Ciências BIológicas / Universidade Federal de Minas Gerais
  • 3 Universidade Federal de Minas Gerais
  • 4 Biotechnology and Innovation in Health / Universidade Anhanguera de São Paulo
Track
  • 2. Biological and Pharmacological Activity of Natural Products
Keywords
hydrophilicity
antitumoral activity
neolignans
sodium salts
Nectandra leucantha